GH RESEARCH PLC
NASDAQ: GHRS (GH Research PLC)
Kemas kini terakhir: 2 jam lalu18.81
0.25 (1.35%)
| Penutupan Terdahulu | 18.56 |
| Buka | 18.75 |
| Jumlah Dagangan | 276,709 |
| Purata Dagangan (3B) | 302,756 |
| Modal Pasaran | 1,291,161,344 |
| Harga / Buku (P/B) | 4.96 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Nov 2026 |
| EPS Cair (TTM) | -0.790 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.21% |
| Nisbah Semasa (MRQ) | 29.71 |
| Aliran Tunai Operasi (OCF TTM) | -41.26 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -27.93 M |
| Pulangan Atas Aset (ROA TTM) | -11.97% |
| Pulangan Atas Ekuiti (ROE TTM) | -16.20% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | GH Research PLC | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | NA |
| AI Insight | NA |
| Purata | -0.67 |
|
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 33.88% |
| % Dimiliki oleh Institusi | 68.90% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Lynx1 Capital Management Lp | 30 Jun 2026 | 13,263,288 |
| Bvf Inc/Il | 30 Jun 2026 | 8,650,158 |
| Ra Capital Management, L.P. | 30 Jun 2026 | 7,636,813 |
| Rtw Investments, Lp | 30 Jun 2026 | 5,933,815 |
| Deep Track Capital, Lp | 30 Jun 2026 | 3,333,334 |
| Avoro Capital Advisors Llc | 30 Jun 2026 | 1,800,000 |
| Foresite Capital Management Vi Llc | 30 Jun 2026 | 940,493 |
| Jefferies Financial Group Inc. | 30 Jun 2026 | 712,300 |
| Braidwell Lp | 30 Jun 2026 | 207,240 |
| Boothbay Fund Management, Llc | 30 Jun 2026 | 202,103 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |